ARTICLE | Company News
Teva, Allergan generics news
August 3, 2015 7:00 AM UTC
Allergan will divest its global generic pharmaceuticals business to Teva for $33.8 billion in cash and $6.8 billion in Teva stock. Teva will acquire Allergan’s legacy Actavis global generics business,...